Anuh Pharma Limited (NSE:ANUHPHR)

Market Cap	10.56B
Revenue (ttm)	6.62B
Net Income (ttm)	473.52M
Shares Out	n/a
EPS (ttm)	9.45
PE Ratio	22.30
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	31,944
Average Volume	12,551
Open	209.00
Previous Close	208.05
Day's Range	208.00 - 214.75
52-Week Range	148.05 - 249.95
Beta	n/a
RSI	55.87
Earnings Date	Aug 8, 2025

About Anuh Pharma

Anuh Pharma Limited engages in the manufacture and sale of bulk drugs and chemicals in India. It offers active pharmaceutical ingredients, including macrolides, anti-TB, anti-malarial, anti-bacterial, anti-hypertension, expectorant, quinolones, and intermediates. The company also provides corticosteroids, such as anti-inflammatory, immunosuppressant, anti-pruritic, anti-mitotic, and anti-histamines. It also exports its products. The company was incorporated in 1960 and is headquartered in Mumbai, India.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1960
• Employees: 175
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ANUHPHR

Financial Performance

In 2024, Anuh Pharma's revenue was 6.62 billion, an increase of 2.24% compared to the previous year's 6.47 billion. Earnings were 473.52 million, a decrease of -21.16%.